Study guide

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling

Utah MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC

1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel

2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel

3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement

4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing

4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags

5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records

5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards

6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration

6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting

7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs

7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security

9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database

9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)

10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products

10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales

11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery

11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs

12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards

13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation

13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling

Key Takeaways Explain This Topic AI

Every substance controlled under the federal Controlled Substances Act is also controlled in Utah, along with the substances in Utah's own schedules and list (Utah Code § 58-37-107).

Gabapentin became a Utah Schedule V controlled substance on May 1, 2024, although it is not controlled federally (Utah Code § 58-37-108(2)(e)(iii)).

Utah Schedule III includes any substance containing any quantity of a derivative of barbituric acid, which covers butalbital combination products that federal law exempts.

A codeine combination product is Schedule V at no more than 200 mg per 100 mL and Schedule III at no more than 1.8 g per 100 mL or 90 mg per dosage unit.

Utah Schedule I includes tianeptine, phenibut, and the kratom alkaloids 7-hydroxymitragynine and mitragynine pseudoindoxyl.

Last updated: November 2026

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling

Blueprint item 2.1 covers "requirements for drug uses, limitations, or restrictions." For controlled substances, the starting point is the drug's schedule , which determines prescription, refill, record, inventory, and storage rules.

Two sets of schedules

Federal: 21 U.S.C. § 812 and 21 CFR Part 1308 (DEA, with HHS and FDA scientific input).

Utah: Utah Code § 58-37-108 (Schedules I–V; formerly § 58-37-4) and § 58-37-109 (listed controlled substances, mostly synthetic cannabinoids and cathinones). In addition, § 58-37-107(2) makes every substance listed in the federal Controlled Substances Act a controlled substance in Utah.

When Utah places a drug in a more restrictive schedule than federal law, or controls a drug federal law does not, Utah pharmacies follow the Utah schedule (Section 1.2). Utah's Controlled Substance Advisory Committee (Title 58, Chapter 38a) advises the Legislature on scheduling, and additions are made by statute. When the federal government reschedules an FDA-approved pharmaceutical composition of a Schedule I substance, Utah automatically follows (§ 58-37-108(3)).

The five schedules

Schedule Criteria Examples

I High abuse potential; no accepted medical use; lack of accepted safety Heroin, LSD, MDMA, psilocybin; in Utah also tianeptine , phenibut , 7-hydroxymitragynine , and mitragynine pseudoindoxyl

II High abuse potential; accepted medical use; severe dependence Morphine, oxycodone, hydrocodone (all products since 2014), fentanyl, methadone, hydromorphone, tapentadol; amphetamine, methylphenidate, lisdexamfetamine; cocaine; pentobarbital; dronabinol oral solution (Syndros)

III Less abuse potential than I or II; moderate or low physical or high psychological dependence Buprenorphine, ketamine, anabolic steroids (for example, testosterone), dronabinol capsules (Marinol), codeine combinations of up to 90 mg per dosage unit (Tylenol with Codeine #3 and #4); in Utah, any substance containing a derivative of barbituric acid (so butalbital/acetaminophen/caffeine is Schedule III in Utah )

IV Low abuse potential relative to III Benzodiazepines, zolpidem, eszopiclone, carisoprodol, tramadol, modafinil, phenobarbital, phentermine, suvorexant

V Low abuse potential relative to IV Codeine cough preparations of up to 200 mg per 100 mL, diphenoxylate with atropine (Lomotil), pregabalin, lacosamide, brivaracetam; in Utah, gabapentin

Narcotic combination thresholds

  • Narcotic in combination with non-narcotic active ingredients Schedule III Schedule V
  • Codeine ≤ 1.8 g per 100 mL, or ≤ 90 mg per dosage unit ≤ 200 mg per 100 mL or per 100 g
  • Dihydrocodeine ≤ 1.8 g per 100 mL, or ≤ 90 mg per dosage unit ≤ 100 mg per 100 mL or per 100 g
  • Opium ≤ 500 mg per 100 mL or per 100 g, or ≤ 25 mg per dosage unit ≤ 100 mg per 100 mL or per 100 g
  • Diphenoxylate n/a ≤ 2.5 mg with at least 25 mcg atropine sulfate per dosage unit
  • Difenoxin n/a ≤ 0.5 mg with at least 25 mcg atropine sulfate per dosage unit

Single-entity codeine is Schedule II. A liquid with 240 mg of codeine per 100 mL plus guaifenesin is above the Schedule V limit and is Schedule III .

  • Utah-specific scheduling: what changes in practice
  • Gabapentin (Schedule V since May 1, 2024)

New gabapentin prescriptions require a prescriber with a Utah controlled substance license and a DEA registration . Orders issued before May 1, 2024, including their refills, were not affected.

Pharmacies took an initial gabapentin inventory in May 2024 and include gabapentin in each annual controlled-substance inventory.

Dispensing continues to be reported to the CSD , which has tracked gabapentin since 2019 as a drug of concern.

Schedule V prescription rules apply: refills are valid for one year from issuance (§ 58-37-304(6)(f)), and EPCS is required unless an exemption applies.

Dispensing medical practitioners may not dispense gabapentin, and gabapentin samples may not be distributed in Utah (DOPL gabapentin fact sheet).

Veterinarians acting within veterinary scope are exempt (§ 58-37-308).

Butalbital products

Because Utah's Schedule III covers "any substance that contains any quantity of a derivative of barbituric acid," butalbital/acetaminophen/caffeine products that DEA treats as exempted prescription products are Schedule III in Utah . The CSD rule notes that butalbital dispensing must be reported (R156-37f-203(8)).

Emerging substances

Utah has placed tianeptine ("gas-station heroin"), phenibut , and the potent kratom alkaloids 7-hydroxymitragynine and mitragynine pseudoindoxyl in Schedule I, and lists dozens of synthetic cannabinoids and cathinones in § 58-37-109. Kratom products are separately regulated, and a 2026 statute addresses 7-hydroxymitragynine in kratom products (§ 58-37-406).

Medical cannabis

Federally, marijuana in an FDA-approved drug product and marijuana subject to a state medical marijuana license have been Schedule III since April 28, 2026 (91 FR 22714); all other marijuana remains Schedule I. Utah's medical cannabis program operates under Title 26B, Chapter 4, Part 2 and Title 4, Chapter 41a . A medical cannabis pharmacy under Title 4, Chapter 41a is exempt from pharmacy licensure under Chapter 17b (§ 58-17b-302(1)(b)). Providing pharmacy medical provider services in a medical cannabis pharmacy is not unprofessional conduct (§ 58-17b-502(3)(a)), but violating the cannabis statutes is (§ 58-17b-502(1)(o)). Class A and B pharmacies do not dispense medical cannabis under the Pharmacy Practice Act. FDA-approved cannabidiol products placed in federal Schedule V are Utah Schedule V (§ 58-37-108(2)(e)(ii)).

Scheduling traps

Hydrocodone combinations are Schedule II. Apply CII rules: no refills, the 30-day presentation window, and the one-month supply limit.

Dronabinol: capsules are Schedule III; oral solution is Schedule II.

Gabapentin in Utah is a Schedule V controlled substance, not just a "drug of concern."

Fioricet-type products are Schedule III in Utah.